Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Rahul Atul Parikh"'
Autor:
Hong Wang, Rahul Atul Parikh, Smit Patel, Sudeep K Siddappa Malleshappa, Roy C. Smith, Smith Giri, Kathan Mehta
Publikováno v:
The American Journal of Cardiology. 124:960-965
Venous thromboembolism (VTE) is an important cause of morbidity and mortality in the United States (US). The increasing rates of VTE in the US resulted in the surgeon general issuing a call to action to reduce VTE in 2008. The objective of our study
Autor:
Rahul Atul Parikh, John A. Taylor, Qi Chen, Benjamin L. Woolbright, Ping Chen, Elizabeth Marie Wulff-Burchfield, Jeffrey Holzbeierlein, Roy A. Jensen, Jeanne A. Drisko
Publikováno v:
Journal of Clinical Oncology. 40:e16540-e16540
e16540 Background: Neo-adjuvant cisplatin-based chemotherapy (NAC) is considered standard of care for patients with locally advanced disease. However, ̃40% of patients are cisplatin ineligible (CI) due to renal insufficiency, hearing loss or poor pe
Autor:
Joaquina Celebre Baranda, Gary C. Doolittle, Rahul Atul Parikh, Anup Kasi, Elizabeth Marie Wulff-Burchfield, Benjamin Powers, Robert E. Pluenneke, Marc Steven Hoffmann, Abdulraheem Yacoub, Anwaar Saeed, Larry R. Corum, Tara L. Lin, Weijing Sun, Margaret M. Mooney, Jeffrey Moscow, James H. Doroshow, Brittany Waters, S. Percy Ivy, Steven Gore, Roy A. Jensen
Publikováno v:
Journal of Clinical Oncology. 40:6542-6542
6542 Background: Access to health care including clinical trials (CT) leading to paradigm-changing cancer treatments are critical for high quality cancer care and equity in society. In this report, we highlight methods in accruing to ETCTN wherein un
Autor:
Scott James Weir, Elizabeth R Kessler, Janet Baack Kukreja, Gerald Steven Falchook, Manojkumar Bupathi, Rahul Atul Parikh, Elizabeth Marie Wulff-Burchfield, Robyn Wood, Eugene K. Lee, Tammy Ham, Prasad Dandawate, Shrikant Anant, Benjamin L. Woolbright, Na Zhang, Paul Toren, Michael Dalton, Valentina Zhukova-Harrill, Jay Nicholas Umbreit, William McCulloch, John A. Taylor
Publikováno v:
Journal of Clinical Oncology. 40:e16557-e16557
e16557 Background: Fosciclopirox (F) is being developed for the treatment of non-muscle invasive (NMIBC) and muscle invasive (MIBC) bladder cancer. F is a prodrug which is rapidly and completely metabolized in blood to its active metabolite, ciclopir
Autor:
Sarmad Sadeghi, Rahul Atul Parikh, Denice D. Tsao-Wei, Susan G. Groshen, Ming Li, Leonard Joseph Appleman, Scott T. Tagawa, David M. Nanus, Ana M. Molina, Cheryl Kefauver, Moshe Chaim Ornstein, Brian I. Rini, Robert Dreicer, David I. Quinn, Primo \\'Lucky\\' N. Lara
Publikováno v:
Journal of Clinical Oncology. 40:4529-4529
4529 Background: Immune checkpoint blockade has revolutionized mRCC Tx, but primary and acquired resistance continues to result in poor patient outcomes. OX40 (CD-134) mediates IO resistance. Co-stimulatory OX40 (CD-134) activates exhausted T-cells.
Autor:
Rana R. McKay, Wanling Xie, Archana Ajmera, Biren Saraiya, Mamta Parikh, Edmund Folefac, Adam C. Olson, Elisabeth I. Heath, Rahul Atul Parikh, S. Percy Ivy, Eliezer Mendel Van Allen, Neal Ian Lindeman, Geoffrey Shapiro
Publikováno v:
Journal of Clinical Oncology. 40:119-119
119 Background: Radium-223 is an α-emitting radioisotope that induces DNA double-strand breaks leading to cell death. In preclinical models, PARP inhibitors have shown efficacy as radiosensitizing agents. We designed a phase 1/2 trial to test the sa
Autor:
Meredith McKean, Matthew H. Carabasi, Mark N. Stein, Michael Thomas Schweizer, Jason J. Luke, Vivek Narayan, Rahul Atul Parikh, Russell Kent Pachynski, Jingsong Zhang, Vijay Gopal Reddy Peddareddigari, James Winnberg, Amy Roberts, Jamie Rosen, Pam Hufner, Whitney Gladney, Thomas J. Fountaine, Karen Chagin
Publikováno v:
Journal of Clinical Oncology. 40:94-94
94 Background: CART-PSMA-02 is a multi-center, open-label, phase 1 trial evaluating the safety and feasibility of CART-PSMA-TGFβRDN T-cells (PSMA-CART) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC). PSMA-CART are eng
Publikováno v:
The American Journal of Case Reports
Patient: Female, 64-year-old Final Diagnosis: Plasmacytoid urothelial carcinoma of the bladder Symptoms: Nausea • vomiting Medication:— Clinical Procedure: Cystoscopy Specialty: Oncology Objective: Rare disease Background: Plasmacytoid urothelial
Autor:
Smith Giri, Tapan Mehta, Gautam Valecha, Sudeep K Siddappa Malleshappa, Smit Patel, Kathan Mehta, Rahul Atul Parikh, Roy E. Smith
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230859 (2020)
PLoS ONE
PLoS ONE
A recent study found that approximately 1 in every 6 patients hospitalized for the 1st episode of syncope had an underlying pulmonary embolism (PE). As current guidelines do not strongly emphasize evaluation for PE in the workup of syncope, we hypoth
Autor:
Elaine T. Lam, Jacob P Zaemes, Michael B. Atkins, Katharine Collier, Ajjai Alva, Dharmesh Gopalakrishnan, Sabah Alaklabi, Eric C. Kauffman, Ellen Jaeger, Yuanquan Yang, Saby George, Rahul Atul Parikh, Pedro C. Barata, Joseph J. Park
Publikováno v:
Journal of Clinical Oncology. 39:4568-4568
4568 Background: Advanced sRCC is an aggressive disease with limited responsiveness to chemotherapy and VEGF-targeted therapies. Subgroup analyses from randomized trials showed improved outcomes with ICI, though sample sizes were relatively small. Me